WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 74.50
+0.60 (0.81%)
Oct 31, 2025, 1:06 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.39 billion as of October 31, 2025. Its market cap has increased by 14.77% in one year.
Market Cap
3.39B
Enterprise Value
3.92B
Revenue
1.02B
Ranking
n/a
PE Ratio
18.35
Stock Price
74.50
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.39B, a decrease of -1.23%. That is a compound annual growth rate of -0.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 3.39B | 4.47% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |